AVP-825 Breath-Powered Intranasal Delivery System Containing 22 mg Sumatriptan Powder vs 100 mg Oral Sumatriptan in the Acute Treatment of Migraines (The COMPASS Study): A Comparative Randomized Clinical Trial Across Multiple Attacks

A Randomized, Double-Blind, Placebo-Controlled Study of Breath Powered Nasal Delivery of Sumatriptan Powder (AVP-825) in the Treatment of Acute Migraine (The TARGET Study)

(2014) Roger K. Cady et al.   HEADACHE

Sham Controls in Medical Device Trials

(2014) Rita F. Redberg   NEW ENGLAND JOURNAL OF MEDICINE

What Do Patients Consider to Be the Most Important Outcomes for Effectiveness Studies on Migraine Treatment? Results of a Delphi Study

(2014) Antonia F. H. Smelt et al.   PLoS One

Clinical Implications for Breath-Powered Powder Sumatriptan Intranasal Treatment

(2013) Stewart J. Tepper   HEADACHE

Improved Pharmacokinetics of Sumatriptan With Breath Powered™ Nasal Delivery of Sumatriptan Powder

(2013) Mohammad Obaidi et al.   HEADACHE

Breath Powered Nasal Delivery: A New Route to Rapid Headache Relief

(2013) Per G. Djupesland et al.   HEADACHE

Sex Differences in the Prevalence, Symptoms, and Associated Features of Migraine, Probable Migraine and Other Severe Headache: Results of the American Migraine Prevalence and Prevention (AMPP) Study

(2013) Dawn C. Buse et al.   HEADACHE

Guidelines for controlled trials of drugs in migraine: Third edition. A guide for investigators

(2012) et al.   CEPHALALGIA

Nasal drug delivery devices: characteristics and performance in a clinical perspective—a review

(2012) Per Gisle Djupesland   Drug Delivery and Translational Research

5-HT1D Receptor Immunoreactivity in the Sphenopalatine Ganglion: Implications for the Efficacy of Triptans in the Treatment of Autonomic Signs Associated With Cluster Headache

(2011) Jason J. Ivanusic et al.   HEADACHE

Triptans for the Management of Migraine

(2010) Mollie M. Johnston et al.   DRUGS

Placebo effects: clinical aspects and neurobiology

(2008) B. S. Oken   BRAIN

Tolerability of Acute Migraine Medications: Influence of Methods of Assessment and Relationship With Headache Attributes

(2008) M Feleppa et al.   CEPHALALGIA